top of page
![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Boston_H_color%5B33632%5D_edited.png)
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
Search
Mar 1, 20211 min read
The Importance of the Supportive Care Team in Treating Multiple Myeloma ~ March 4th, 2021
KaryoTalk presents in support of Multiple Myeloma Awareness Month, The Importance of the Supportive Care Team in Treating Multiple...
21 views0 comments
Feb 13, 20211 min read
COHERUS Academy for Biosimilars ~ New Program
Objectives: o To review the clinical profile of UDENYCA®, including mechanism of action, efficacy, safety, indications, and dosing o To...
25 views0 comments
Feb 13, 20211 min read
A discussion and Q&A regarding polycythemia vera ~ SAVE THE DATE ~ 3/25/21
Register at http://bit.ly/PharmaEssentiaBroadcast
28 views0 comments
Feb 13, 20211 min read
Science for a Better Life ~ Colorectal Cancer - Disease Overview ~ 4/28/21
BAYER cordially invites you to attend the following Virtual non-CME Educational Opportunity: STIVARGA and NEXAVAR 2 Colorectal Cancer -...
12 views0 comments
Feb 8, 20211 min read
Finding Compassion Satisfaction and Resilience during the COVID 19 Pandemic
Moderated by Nellee Fine, RN, MSN, AOCN and Cynthia Medeiros, LICSW The panelists include Dana Cameron, RN, BSN, OCN, Nurse Navigator,...
49 views0 comments
Jan 30, 20211 min read
TAGRISSO in the Treatment of Resectable NSCLC with EGFR Exon 19 Deletions or Exon 21 L858R Mutations
This 60-minute program includes a presentation and a question-and-answer session about the adjuvant treatment of resectable EGFR...
25 views0 comments
Jan 30, 20211 min read
A program on an FDA-approved treatment option metastatic Urothelial Carcinoma ~ PADCEV
PRESENTED BY Daniel Landau, MD Section Chief Hematology/Oncology Orlando Health UF Health Cancer Center Orlando, FL DATE AND TIME...
17 views0 comments
Jan 27, 20211 min read
Patient Access Services and Reimbursement Overview
OBJECTIVES: - Describe the patient access services available through Coherus COMPLETE. - Explain coding and the coverage and...
11 views0 comments
Jan 15, 20211 min read
Impact of Long-Term Echelon-1 Data in Stage III/IV CHL
Thursday, January 21st, 2021 6:30PM and 9:00PM Sponsored by Seagen For more information visit the following link:...
14 views0 comments
Jan 6, 20211 min read
TAZVERIK (tazemetostat) ~ Relapsed or Refractory Follicular Lymphoma
Don't miss this new upcoming event! Click image above to register! Event flyer attached below.
19 views0 comments
Dec 5, 20201 min read
TAZVERIK ~ Now Approved ~ Virtual Talk Thursday, 12/10/20 @ 5:00PM
TAZVERIK™ (tazemetostat) is indicated for the treatment of:∙Adult patients with relapsed or refractory follicular lymphoma whose tumors...
6 views0 comments
Nov 19, 20200 min read
10 views0 comments
Nov 2, 20201 min read
A Treatment Option for the Management of Patients With First-Line NSCLC & Metastatic Melanoma
A Treatment Option for the Management of Certain Patients with First-Line NSCLC & Unresectable Metastatic Melanoma VIRTUAL EVENT Click on...
21 views0 comments
Oct 28, 20202 min read
BONS Members ONLY ~ New Evidence in First-Line AML & Exploring Outcomes
BONS Members ONLY! Click date links below to REGISTER through Boston ONS. Tuesday, November 10th 5PM Tuesday, November 10th 8PM Thursday,...
27 views0 comments
Oct 28, 20201 min read
Combining the HER2+ Breast Cancer Antibodies You Know in One Fixed-Dose Subcutaneous Injection ~ NEW
PROGRAM OBJECTIVES: Provide product overview including indication, important safety information, dosing, and administration Review...
21 views0 comments
Oct 11, 20201 min read
Introducing BLENREP (belantamab mafodotin-blmf) ~
Presented by Jamie Mortellite, MSN, ACNP-BC GlaxoSmithKline Date and Time October 20th @ 6:30PM RSVP Jamie Mortellite @...
45 views1 comment
Oct 7, 20201 min read
IMBRUVICA (IBRUTINIB) With A Focus on Walsenstrom's Macroglobulinemia (WM) ~ TOMORROW @ 12:15pm
Click on either image above to link directly to registration!
15 views0 comments
Oct 7, 20200 min read
26 views0 comments
Sep 30, 20201 min read
A Treatment Option for the Management of Certain Patients With First-Line Non-Small Cell Lung Cancer
You are cordially invited by your Bristol Myers Squibb representative to attend a product presentation that will focus on: A Treatment...
31 views0 comments
Sep 30, 20201 min read
Protecting Patients with NERLYNX the only HER2-directed small molecule approved by the FDA ~ Oct 7th
PLEASE REGISTER ONLINE AT: PUMAREG.TSGMEDED.COM Enter Event Code:51684 This program is sponsored by Puma Biotechnology, Inc. This is not...
9 views0 comments
bottom of page